AR038306A1 - Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato - Google Patents

Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato

Info

Publication number
AR038306A1
AR038306A1 ARP030100196A ARP030100196A AR038306A1 AR 038306 A1 AR038306 A1 AR 038306A1 AR P030100196 A ARP030100196 A AR P030100196A AR P030100196 A ARP030100196 A AR P030100196A AR 038306 A1 AR038306 A1 AR 038306A1
Authority
AR
Argentina
Prior art keywords
etil
amino
fluoren
benzoate
phenyl
Prior art date
Application number
ARP030100196A
Other languages
English (en)
Spanish (es)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038306A1 publication Critical patent/AR038306A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP030100196A 2002-01-23 2003-01-23 Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato AR038306A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200793A FR2834891B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate

Publications (1)

Publication Number Publication Date
AR038306A1 true AR038306A1 (es) 2005-01-12

Family

ID=27589557

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100196A AR038306A1 (es) 2002-01-23 2003-01-23 Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato

Country Status (3)

Country Link
AR (1) AR038306A1 (fr)
FR (1) FR2834891B1 (fr)
WO (1) WO2003061647A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2966828B1 (fr) * 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
FR2677647B1 (fr) * 1991-06-14 1993-08-20 Adir Nouveaux derives de benzoate d'ethanolamine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.

Also Published As

Publication number Publication date
FR2834891B1 (fr) 2004-02-27
WO2003061647A1 (fr) 2003-07-31
FR2834891A1 (fr) 2003-07-25

Similar Documents

Publication Publication Date Title
IL165383A (en) Pharmaceutical compositions comprising a salt or co-crystal of celecoxib, surfactant and a cellulose derivative
ECSP055568A (es) Composición de comprimido de liberación sostenida de pramipexol
GEP20074047B (en) Pramipexole once-daily dosage form
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
IS8461A (is) 2-(3,4-dímetýlfenýl)-4-{[2-hýdroxý-3'(1H-tetrasól-5-ýl)bífenýl-3-ýl]-hýdrasónó}-5-metýl-2,4-díhýdrópýrasól-3-ónkólín
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
SE0101932D0 (sv) Pharmaceutical combinations
MXPA05011176A (es) Derivados de carboxamida como agentes antidiabeticos.
BRPI0415053B8 (pt) inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
EP1602645A4 (fr) Derive heterocyclique azote contenant du styryl 2,6-disubstitue
BR0314129A (pt) Formulações de liberação modificadas de oxcarbazepina e derivados destas
AR038305A1 (es) Composicion farmaceutica dispersable oralmente de perindopril
AR038206A1 (es) Composicion farmaceutica dispersable oralmente de ivabradina
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
GB0212410D0 (en) Organic compounds
AR038306A1 (es) Composicion farmaceutica dispersable oralmente de 2-({2-metoxi-2-[(3-trifluorometil)fenil]etil}amino)etil-4-(2-{[2-(9h-fluoren-9-il)acetil]amino}etil)benzoato
WO2004048381A3 (fr) Nouveaux composes de pyrazoloazepine utilises en tant qu'agents pharmaceutiques
BR0315537A (pt) Pró-drogas ativadas por peptìdeo desformilase

Legal Events

Date Code Title Description
FB Suspension of granting procedure